Key result
In patients with metabolic syndrome, there were no statistically significant differences in the frequency of abnormal changes between the arterial stiffness parameters CAVI and kfPWV, both of which correlated highly with age.
Why the study?
Do the arterial stiffness parameters CAVI and kfPWV differ in their frequency of elevation among patients with metabolic syndrome?
Cross-Sectional (n=100)
No
Do the arterial stiffness parameters CAVI and kfPWV differ in their frequency of elevation among patients with metabolic syndrome?
In patients with metabolic syndrome, both CAVI and kfPWV are similarly elevated and highly correlated with age, suggesting both are useful markers of arterial stiffness in this population.
Answers are grounded in this paper and cite their sources.
CAVI and kfPWV may be comparably useful stiffness markers in metabolic syndrome; cross-sectional data leaves open prospective outcome validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Urazalina et al. (2018) conducted a cross-sectional in Metabolic syndrome (n=100). Arterial stiffness measurement (CAVI and kfPWV) was evaluated on Frequency of abnormal changes in CAVI and kfPWV parameters. In patients with metabolic syndrome, there were no statistically significant differences in the frequency of abnormal changes between the arterial stiffness parameters CAVI and kfPWV, both of which correlated highly with age.
Synapse has enriched 10 related papers. Consider them for comparative context: